Background. The response to endocrine therapy is not entirely predictable from the estrogen
receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors …

Estradiol receptor (ER) and progesterone receptor (PR) content along with the cytosol and
plasma estrone and estradiol levels in 15 premenopausal and 26 postmenopausal women …

The presence of estrogen-binding sites in human renal cell carcinomas appears certainly
demonstrated. The authors analyze the clinical contributions which may be obtained from …

Colon cancer incidence and mortality rates are lower in females compared with males, and
numerous epidemiological studies suggest that estrogen replacement therapy (ERT) …

The ER‐D5 antigen is a protein associated with the estrogen receptor that is present only in
estrogen receptor‐positive tissues. To clarify the estrogen receptor in colon cancer, the …

Background: Altered expression of estrogen receptors alpha and beta (ERα and ERβ) has
been hypothesized to play a role in carcinogenesis. However, little is known about the sex …

• One hundred three diverse benign and malignant human tissues have been assayed for
estrogen receptor proteins. Receptors were detected in many endocrine and nonendocrine …

Estrogen receptor (ER) in breast tumors of patients who were operated at Keio University
Hospital was examined routinely. During 10 months from May 1976 till March 1977, 65 …

We performed a retrospective analysis for the presence of estrogen receptors (ERs) in
known cases of adenocarcinoma of the colon, pancreas, and lung. Estrogen receptor status …

The estrogen receptor (ER) is a unique protein present within the cell cytosol of estrogen
sensitive tissues which exhibits high affinity binding for estrogenic steroids. The presence of …